市场调查报告书
商品编码
1452728
全球子宫内膜消融市场规模、份额、成长分析(按类型和最终用途)- 2024-2031 年产业预测Global Endometrial Ablation Market Size, Share, Growth Analysis, By Type(Devices, Cryoablation), By End-use(Hospitals, Clinics) - Industry Forecast 2024-2031 |
2022年全球子宫内膜消融市场规模将为35.5亿美元,从2023年的36.9亿美元增长到2031年的50.5亿美元,并在预测期内持续增长(2024年至2031年期间CAGR预计为4.00% ) 2031)。
月经疼痛、PCOD、异常阴道出血等妇科疾病发病率的上升以及人们对子宫内膜去除术益处的认识不断提高,推动了子宫内膜去除术和设备的需求激增。例如,疾病预防控制中心指出,每年有 1,000 万美国女性经历月经痛。与手术替代方案相比,这些手术的技术进步和卓越优势正在促进市场成长。微创子宫内膜移除术改变了这一现状,它提供了一种降低风险和复杂性的日间手术,可以原位破坏子宫内膜。异常子宫出血 (AUB) 影响全球 3% 至 30% 的育龄妇女,使其成为一个重要的驱动因素。政府和私人组织正在优先考虑妇女的健康,印度等国家正在采取诸如免除健康保险费税等措施。这些奖励可望推动治疗方法的普及,进而推动市场扩张。然而,市场成长的潜在限制包括感染疾病等风险以及与子宫内膜消融相关的子宫壁和肠道併发症。儘管有这些挑战,AUB 的盛行率仍然是育龄妇女的重大问题,据估计,仅在印度,AUB 的盛行率就达到 17.9%,这导致对有效治疗的持续需求。事实表明确实如此。
Global Endometrial Ablation Market size was valued at USD 3.55 billion in 2022 and is poised to grow from USD 3.69 billion in 2023 to USD 5.05 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).
The surging demand for endometrial ablation procedures and devices is propelled by the rising occurrence of gynecological disorders such as menorrhagia, PCOD, and abnormal vaginal bleeding, coupled with an increased awareness of the advantages of endometrial ablation. For instance, the CDC notes that 10 million American women experience menorrhagia annually. Technological advancements and the superior benefits of these procedures compared to surgical alternatives contribute to the market's growth. Minimally invasive endometrial ablation techniques have transformed the landscape by providing day-care procedures with reduced risk and complexity for in-situ destruction of the endometrium. Abnormal Uterine Bleeding (AUB), impacting 3 to 30% of reproductive-aged women globally, serves as a pivotal driver. Governments and private organizations prioritize women's health, evident in initiatives like tax exemptions for health insurance premiums in countries such as India. These incentives are poised to enhance treatment adoption and, subsequently, foster market expansion. Nevertheless, potential constraints on market growth include risks such as infection and complications like uterine wall or bowel tearing associated with endometrial ablation procedures. Despite these challenges, the prevalence of AUB remains a significant concern for reproductive-aged women, with an estimated 17.9% prevalence in India alone, indicating a sustained demand for effective treatments.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endometrial Ablation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Endometrial Ablation Market Segmental Analysis
The Global Endometrial Ablation Market is segmented on the basis of Type, End-use, and Regional. Based on Type the market is segmented as, Devices, Cryoablation, Radiofrequency Ablation, Hydrothermal Ablation, Thermal Balloon, Microwave Energy, Procedures. Based on End-use the market is segmented as, Hospitals, Clinics, Ambulatory Surgery Centers. Based on Regional the market is segmented as, North America, Europe, Asia Pacific, and LAMEA.
Drivers of the Global Endometrial Ablation Market
The rising prevalence of gynecological conditions like menorrhagia, abnormal vaginal bleeding, and polycystic ovary syndrome (PCOS) significantly propels the growth of the endometrial ablation market. The presence of these disorders generates a considerable need for minimally invasive treatment alternatives, with endometrial ablation emerging as a sought-after solution to address such demands.
Restraints in the Global Endometrial Ablation Market
Endometrial ablation procedures may not be appropriate for every patient, as the intervention carries inherent risks and potential complications. Factors such as the risk of infection, tearing of the uterine wall or bowel, and unintended outcomes could impede the expansion of the market for these procedures. It is crucial to carefully consider these associated adverse effects when assessing the suitability of endometrial ablation for individual patients.
Market Trends of the Global Endometrial Ablation Market
The market is witnessing a notable uptick in technological progress, giving rise to the creation of cutting-edge endometrial ablation devices that are not only innovative but also more efficient. These breakthroughs specifically target improvements in precision, safety, and overall procedural effectiveness, thereby drawing interest from both patients and healthcare providers alike.